Founded in 1994, we are one of the earliest developed enterprises in the circle of microbiological in vitro diagnostic reagents in China. Zhuhai Encode Medical Engineering Co., Ltd. integrates research, production and sale. Since the very beginning, Encode has been consistently engaged in the research and development of in-vitro diagnostic reagents. We have researched and developed series of microbiological and immunology reagents, which are used for mycoplasma, chlamydia, pneumonia, pathogenic fungus, tuberculosis, bacterial vaginosis and neisseria gonorrhoeae laboratory diagnosis. The sales network has covered all over the country.In 2005, we constructed our study, research & manufacturing base in Zhuhai, a predominant city of biotech industry in the south of China. Our base covers 15,000sqm, with automatic manufacturing lines including freeze-dry lines and over 2,000sqm standard GMP air-purified workshops.We obtained ISO9001 & ISO13485 (Especially in Medical Device Manufacture Management) quality management system certifications in 2006. From 2007 to 2009, after the new in-vitro diagnostic reagent regulations were issued, we successfully passed the rigorous quality management system evaluation organized by SFDA and GDFDA. We also got CCC certificate for our main products-Mycoplasma Susceptibility Test Kits, Fungi Susceptibility Test Kits, Chlamydia Trachomatis Antigen Testing Kits (Colloidal Gold) and M. tuberculosis Antibody (IgG) Testing Kits (Colloidal Gold).Under "industry-study-research" collaboration mode, Encode has established extensive and cooperative ties with Lanzhou University, South China University of Technology and Jinan University and has become a teaching and practice base of College of Life Science, Lanzhou University, South China University of Technology and Zhuhai Health School. Encode enjoys a high reputation in this field and has been rated as one of the high-tech enterprises in Guangdong. Our president Sun Yifeng was elect